SARS-CoV-2 Variants - Coronavirus COVID-19 **NO DISCUSSION**

Welcome to Websleuths!
Click to learn how to make a missing person's thread

DNA Solves
DNA Solves
DNA Solves

Statement on the antigen composition of COVID-19 vaccines​

26 April 2024

  • “SARS-CoV-2 continues to circulate and evolve with important genetic and antigenic evolution of the spike protein.

  • The objective of an update to COVID-19 vaccine antigen composition is to enhance vaccine-induced immune responses to circulating SARS-CoV-2 variants.

  • As the virus is expected to continue to evolve from JN.1, the TAG-CO-VAC advises the use of a monovalent JN.1 lineage as the antigen in future formulations of COVID-19 vaccines.

  • In accordance with WHO SAGE policy, vaccination programmes should continue to use any of the WHO emergency-use listed or prequalified COVID-19 vaccines and vaccination should not be delayed in anticipation of access to vaccines with an updated composition.”


* more at link
 

Staff online

Members online

Online statistics

Members online
98
Guests online
1,684
Total visitors
1,782

Forum statistics

Threads
604,787
Messages
18,177,095
Members
232,926
Latest member
Mydermarie26
Back
Top